Biosimilars and Biologic Drugs

Biosimilars are the generic version of biological. A biosimilar is a biologic therapeutic item which is duplicate of a unique item that is produced by an alternate organization. It is the new buzz word in pharmaceutical industry. Biosimilars are highly comparable to licensed reference product not accept minor differences in clinically passive components; also there are no clinically needful disparities between the biologicals and the reference product in terms of safety, purity, and potency.

Biologic Drugs are genetically occurred from a living organism, such as a virus, protein, to maintain the body’s natural response to infections and diseases. Biologics target proteins, and cells responsible for the manifestation and damage of rheumatoid arthritis and other types of inflammatory arthritis. The proteins targeted include tumors necrosis factor (TNF), interleukin-1 (IL-1) and interleukin-6 (IL-6), which shows effect in joint inflammation. Biologics are reserved for people whose arthritis has not retorted well to disease-modifying anti rheumatic drugs (DMARDs).

 

  • Analytical Strategies for Biosimilars
  • Clinical development of biosimilars
  • Globalization of Biosimilars
  • Biosimilar GMP protein analysis
  • Advances in biological products
  • Generic biological drugs

Related Conference of Biosimilars and Biologic Drugs

October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-07, 2018

18th Annual Pharma Middle East Congress

Radisson Blu Hotel, Yas Island, Abu Dhabi, UAE
November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
January 30-31, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Seoul, South Korea
January 31-February 01, 2019

9th World Congress on Chromatography

Paris | France
February 20-21, 2019

World Congress on Drug Discovery and Drug Design

Singapore
February 22-23, 2019

13th World Drug Delivery Summit

San Francisco, USA
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
March 27-28, 2019

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
April 04-06, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Auckland, NewZealand
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
April 17-18, 2019

International Conference on Global Analytica

Osaka, Japan

April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
May 9-11, 2019

11th World Congress on Neuropharmacology

Prague, Czech Republic
May 20-22, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
March 22-23, 2019

5th International Conference on Antibiotics

Orlando, USA
June 17-18, 2019

7 th European Biopharma Congress

Stockholm, Sweden
June 17-18, 2019

14th World Congress on Pharmacology and Drug Safety

Lisbon, Portugal
June 27-29, 2019

18th Annual Congress on Pharmaceutics & Drug Delivery Systems

Amsterdam, Netherlands
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA

August 19-20, 2019

24th World Congress on Pharmacology

Vienna, Austria

Biosimilars and Biologic Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in